Baolingbao Biology Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.061x

Baolingbao Biology Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Baolingbao Biology Co Ltd (002286) has a cash flow conversion efficiency ratio of 0.061x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥134.96 Million ≈ $19.75 Million USD) by net assets (CN¥2.20 Billion ≈ $322.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Baolingbao Biology Co Ltd (2006–2025)

Cash flow conversion efficiency of Baolingbao Biology Co Ltd from 2006 to 2025. This chart illustrates how Baolingbao Biology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Baolingbao Biology Co Ltd for real-time trading data and today's change.

Baolingbao Biology Co Ltd Cash Flow Conversion Ratio Explained

Baolingbao Biology Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Baolingbao Biology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Baolingbao Biology Co Ltd ranked by their cash flow conversion efficiency. Also see Baolingbao Biology Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Irish Residential Properties
IR:IRES
0.019x
ScinoPharm Taiwan Ltd
TW:1789
0.019x
Beijing Leadman Biochemistry Co Ltd
SHE:300289
0.007x
Anpec Electronics
TWO:6138
0.041x
Yorhe Fluid Intelligent Control Co Ltd
SHE:002795
0.106x
First Foundation Inc.
NYSE:FFWM
-0.027x
Caisse Regionale de Credit Agricole Mutuel de Normandie Seine SC
PA:CCN
0.003x
Cheng Uei Precision Industry Co Ltd
TW:2392
0.146x

Annual Cash Flow Conversion Efficiency for Baolingbao Biology Co Ltd (2006–2025)

The table below shows the annual cash flow conversion efficiency of Baolingbao Biology Co Ltd from 2006 to 2025. Review 002286 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥2.23 Billion
≈ $326.85 Million
CN¥259.36 Million
≈ $37.95 Million
0.116x -4.69%
2024-12-31 CN¥2.04 Billion
≈ $298.74 Million
CN¥248.72 Million
≈ $36.40 Million
0.122x -14.39%
2023-12-31 CN¥1.98 Billion
≈ $290.25 Million
CN¥282.28 Million
≈ $41.31 Million
0.142x +825.49%
2022-12-31 CN¥2.00 Billion
≈ $293.30 Million
CN¥30.82 Million
≈ $4.51 Million
0.015x -86.48%
2021-12-31 CN¥1.81 Billion
≈ $265.33 Million
CN¥206.27 Million
≈ $30.18 Million
0.114x -54.34%
2020-12-31 CN¥1.60 Billion
≈ $234.04 Million
CN¥398.46 Million
≈ $58.31 Million
0.249x +153.58%
2019-12-31 CN¥1.57 Billion
≈ $229.30 Million
CN¥153.95 Million
≈ $22.53 Million
0.098x +13.86%
2018-12-31 CN¥1.54 Billion
≈ $225.64 Million
CN¥133.05 Million
≈ $19.47 Million
0.086x +456.56%
2017-12-31 CN¥1.53 Billion
≈ $223.17 Million
CN¥-36.91 Million
≈ $-5.40 Million
-0.024x -133.49%
2016-12-31 CN¥1.51 Billion
≈ $220.69 Million
CN¥108.98 Million
≈ $15.95 Million
0.072x +37.85%
2015-12-31 CN¥1.48 Billion
≈ $216.29 Million
CN¥77.49 Million
≈ $11.34 Million
0.052x -25.34%
2014-12-31 CN¥1.45 Billion
≈ $212.09 Million
CN¥101.77 Million
≈ $14.89 Million
0.070x +17.74%
2013-12-31 CN¥1.44 Billion
≈ $210.03 Million
CN¥85.60 Million
≈ $12.53 Million
0.060x -48.22%
2012-12-31 CN¥817.45 Million
≈ $119.62 Million
CN¥94.15 Million
≈ $13.78 Million
0.115x -48.98%
2011-12-31 CN¥760.53 Million
≈ $111.29 Million
CN¥171.70 Million
≈ $25.12 Million
0.226x +478.31%
2010-12-31 CN¥703.11 Million
≈ $102.89 Million
CN¥27.45 Million
≈ $4.02 Million
0.039x -41.88%
2009-12-31 CN¥662.61 Million
≈ $96.96 Million
CN¥44.51 Million
≈ $6.51 Million
0.067x -85.56%
2008-12-31 CN¥238.05 Million
≈ $34.83 Million
CN¥110.77 Million
≈ $16.21 Million
0.465x +13.88%
2007-12-31 CN¥193.28 Million
≈ $28.28 Million
CN¥78.98 Million
≈ $11.56 Million
0.409x +140.46%
2006-12-31 CN¥112.53 Million
≈ $16.47 Million
CN¥19.12 Million
≈ $2.80 Million
0.170x --

About Baolingbao Biology Co Ltd

SHE:002286 China Biotechnology
Market Cap
$489.30 Million
CN¥3.34 Billion CNY
Market Cap Rank
#12099 Global
#3514 in China
Share Price
CN¥8.80
Change (1 day)
-1.90%
52-Week Range
CN¥7.21 - CN¥11.61
All Time High
CN¥23.40
About

Baolingbao Biology Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of functional sugar in China and internationally. The company offers prebiotics, including galacto-oligosaccharides, isomaltooligosaccharides, fructooligosaccharides, and xylooligosaccharides; sugar alcohols and sources, such as erythritol, trehalose, crystallized fructose, a… Read more